As of Jun 02
| +0.08 / +6.45%|
The 3 analysts offering 12-month price forecasts for Citius Pharmaceuticals Inc have a median target of 6.00, with a high estimate of 8.00 and a low estimate of 4.00. The median estimate represents a +354.55% increase from the last price of 1.32.
The current consensus among 3 polled investment analysts is to Buy stock in Citius Pharmaceuticals Inc. This rating has held steady since March, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.